Chewy, Inc.
Chewy, Inc. (CHWY) Financial Performance & Income Statement Overview
Explore the financials of Chewy, Inc. (CHWY), including yearly and quarterly data on income, cash flow, and balance sheets.
Chewy, Inc. (CHWY) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Chewy, Inc. CHWY financial performance.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $3.25B | $2.88B | $2.86B | $2.88B |
| Cost of Revenue | $2.32B | $2.03B | $2.01B | $2.05B |
| Gross Profit | $926.003M | $843.87M | $843.84M | $826.99M |
| Gross Profit Ratio | $0.29 | $0.29 | $0.30 | $0.29 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $8.90M |
| SG&A Expenses | $935.72M | $818.24M | $811.78M | $762.37M |
| Operating Expenses | $935.72M | $818.24M | $811.78M | $762.37M |
| Total Costs & Expenses | $3.26B | $2.85B | $2.83B | $2.81B |
| Interest Income | $5.05M | $5.25M | $14.43M | $15.86M |
| Interest Expense | $1.32M | $1.35M | $1.51M | $1.33M |
| Depreciation & Amortization | $28.50M | $28.98M | $28.45M | $28.00M |
| EBITDA | $27.13M | $59.83M | $76.48M | $107.72M |
| EBITDA Ratio | $0.008 | $0.02 | $0.03 | $0.04 |
| Operating Income | -$9.71M | $25.63M | $32.05M | $64.63M |
| Operating Income Ratio | -$0.003 | $0.009 | $0.01 | $0.02 |
| Other Income/Expenses (Net) | $7.01M | $3.87M | $14.46M | $13.76M |
| Income Before Tax | -$2.70M | $29.50M | $46.51M | $78.38M |
| Income Before Tax Ratio | -$0.001 | $0.01 | $0.02 | $0.03 |
| Income Tax Expense | -$25.49M | $25.57M | -$252.60M | $11.48M |
| Net Income | $22.79M | $3.93M | $299.12M | $66.90M |
| Net Income Ratio | $0.007 | $0.001 | $0.10 | $0.02 |
| EPS | $0.06 | $0.009 | $0.70 | $0.15 |
| Diluted EPS | $0.05 | $0.009 | $0.68 | $0.15 |
| Weighted Avg Shares Outstanding | $407.83M | $414.36M | $429.38M | $434.87M |
| Weighted Avg Shares Outstanding (Diluted) | $424.13M | $426.57M | $437.88M | $436.42M |
The company's financials show resilient growth, with revenue advancing from $2.88B in Q1 2024 to $3.25B in Q4 2024. Gross profit remained healthy with margins at 29% in Q4 2024 compared to 29% in Q1 2024. Operating income hit -$9.71M last quarter, sustaining a consistent -0% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $27.13M. Net income rose to $22.79M, while earnings per share reached $0.06. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan